Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications”

While oncogenic mutations of head and neck squamous cell carcinomas (HNSCC) in head and neck malignancies are uncommon, analysis using next-generation sequencing (NGS) technologies is growing. Further, single-cell analysis is being developed to overcome cancer cell heterogeneity and improve the poor...

Full description

Bibliographic Details
Main Author: Hiroyuki Tomita
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Journal of Clinical Medicine
Subjects:
ngs
Online Access:https://www.mdpi.com/2077-0383/8/11/1905
id doaj-69be0466ce5c403facb7bc2ed2b5eead
record_format Article
spelling doaj-69be0466ce5c403facb7bc2ed2b5eead2020-11-25T02:27:40ZengMDPI AGJournal of Clinical Medicine2077-03832019-11-01811190510.3390/jcm8111905jcm8111905Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications”Hiroyuki Tomita0Department of Tumor Pathology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, JapanWhile oncogenic mutations of head and neck squamous cell carcinomas (HNSCC) in head and neck malignancies are uncommon, analysis using next-generation sequencing (NGS) technologies is growing. Further, single-cell analysis is being developed to overcome cancer cell heterogeneity and improve the poor survival of patients. However, it is important for researchers to know how to use this information to improve patients’ survival.https://www.mdpi.com/2077-0383/8/11/1905head and neck cancerngssquamous cell carcinoma
collection DOAJ
language English
format Article
sources DOAJ
author Hiroyuki Tomita
spellingShingle Hiroyuki Tomita
Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications”
Journal of Clinical Medicine
head and neck cancer
ngs
squamous cell carcinoma
author_facet Hiroyuki Tomita
author_sort Hiroyuki Tomita
title Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications”
title_short Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications”
title_full Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications”
title_fullStr Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications”
title_full_unstemmed Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications”
title_sort comment from the editor on the special issue “head and neck critical illness: basic and clinical research implications”
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2019-11-01
description While oncogenic mutations of head and neck squamous cell carcinomas (HNSCC) in head and neck malignancies are uncommon, analysis using next-generation sequencing (NGS) technologies is growing. Further, single-cell analysis is being developed to overcome cancer cell heterogeneity and improve the poor survival of patients. However, it is important for researchers to know how to use this information to improve patients’ survival.
topic head and neck cancer
ngs
squamous cell carcinoma
url https://www.mdpi.com/2077-0383/8/11/1905
work_keys_str_mv AT hiroyukitomita commentfromtheeditoronthespecialissueheadandneckcriticalillnessbasicandclinicalresearchimplications
_version_ 1724841559469326336